Research Library
Curated Studies & Clinical Data
A growing library of peer-reviewed studies, clinical trial data, and systematic reviews organized by compound. Every citation is linked to its primary source.
Tirzepatide and SGLT2 Inhibitors for Heart Failure With Preserved Ejection Fraction and Obesity: Entering a New Cardiometabolic Therapeutic Era
Endocrinology, diabetes & metabolism;9(5):e70298
Effectiveness & safety of semaglutide in weight reduction in obese nondiabetic patients: A systematic review and meta-analysis
Medicine;105(31):e49986
[An historical overview of GLP-1/GIP incretins. From hormone to “swiss-army knife” medications]
Biologie aujourd'hui, 2026;220(1-2):9-24
Hypertensive disorders of pregnancy and GLP-1 receptor agonist timing: a systematic review and meta-analysis
Endocrine, 2026;91(1)
Early changes in renal function do not appear to mediate cardiovascular risk with dapagliflozin plus semaglutide: a real-world observational hypothesis-generating cohort study
Expert review of cardiovascular therapy, 2026
Retatrutide effects on diabetic rats’ cognition
Lab animal;55(8):287
Abrupt Smoking Cessation Due to Sensory Aversion Following Tirzepatide Initiation
The primary care companion for CNS disorders, 2026;28(4)
Design of a metabolically-stable peptide therapeutic with triple-hormone-receptor agonist activity
Journal of computer-aided molecular design, 2026;40(1)
Effect of Medications for Type 2 Diabetes on Cardiovascular Events and Mortality: A Comprehensive Pairwise and Network Meta-Analysis
Diabetes, obesity & metabolism, 2026
Incorporating estimands into meta-analyses of clinical trials
Research synthesis methods, 2026;:1-28
Outpatient Dispensing Patterns and Changes in Tirzepatide Strength Mix in Japan: A Study Using the National Open Claims Data
Cureus, 2026;18(7):e113681
Prescription Sequence Symmetry Analysis of Glucagon-Like Peptide-1 Receptor Agonists and Neuropsychiatric Conditions
Clinical pharmacology and therapeutics, 2026
Impurities and Potential Immunogenicity Associated With Follow-on and Compounded Glucagon-like Peptide-1 Receptor Agonists
Pharmaceutical research, 2026
Concurrent initiation of tirzepatide and biologics improves patient-reported outcomes in obese psoriatic arthritis: a propensity score-matched study
RMD open, 2026;12(3)
Oral Semaglutide for Alcohol Use Disorder: A Randomized Clinical Trial
The American journal of psychiatry, 2026;:appiajp20260003
PYY3-36 potentiates Semaglutide‑mediated mitochondrial modulation in MASLD
American journal of physiology. Endocrinology and metabolism, 2026
Stable pentadecapeptide therapy counteracts gentamicin-induced nephrotoxicity via nitric oxide-system modulation: evidence from a triple nitric oxide-agent approach in rats
Journal of physiology and pharmacology : an official journal of the Polish Physiological Society, 2026;77(3):377-395
Semaglutide improves MASLD and MASH in people with HIV: The SLIM LIVER study
HIV medicine, 2026
A Novel Microfluidic Strategy for the Fabrication of α-Lactalbumin Nanomicelles Paves a New Path for Antiobesity Technology
Advanced healthcare materials, 2026;:e71486
Dose-dependent effects of oral semaglutide on arterial stiffness and the additive role of SGLT-2 inhibitors in type 2 diabetes
British journal of clinical pharmacology, 2026